Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study-Reference-Cited by-同舟云学术

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

Published:2018-08 Issue:2 Volume:155 Page:443-457.e17
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Vilar-Gomez Eduardo^ORCID,Calzadilla-Bertot Luis^ORCID,Wai-Sun Wong Vincent,Castellanos Marlen,Aller-de la Fuente Rocio,Metwally Mayada,Eslam Mohammed,Gonzalez-Fabian Licet^ORCID,Alvarez-Quiñones Sanz María,Conde-Martin Antonio Felix,De Boer Bastiaan,McLeod Duncan,Hung Chan Anthony Wing,Chalasani Naga,George Jacob,Adams Leon A.,Romero-Gomez Manuel^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference64 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease;European Association for the Study of the Liver (EASL);J Hepatol,2016

3. Nonalcoholic fatty liver disease a systematic review;Rinella;JAMA,2015

4. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe;Younossi;Hepatology,2016

5. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

Cited by 590 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. Association of healthy lifestyles with risk of all-cause and cause-specific mortality among individuals with metabolic dysfunction-associated steatotic liver disease: results from the DFTJ cohort;Annals of Medicine;2024-09-09

3. Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis;Diabetes, Obesity and Metabolism;2024-09-04

4. Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis;Hepatology International;2024-08-16

5. Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression;International Journal of Molecular Sciences;2024-08-08